Michael Jung
Fondateur chez Enlibrium, Inc.
Profil
Michael Jung is the founder of Aragon Pharmaceuticals, Inc. (founded in 2009) and Seragon Pharmaceuticals, Inc. (founded in 2013).
He is also the founder of Enlibrium, Inc. Dr. Jung's current job is as a Professor at the University of California, Berkeley.
Postes actifs de Michael Jung
| Sociétés | Poste | Début |
|---|---|---|
| University of California, Berkeley | Corporate Officer/Principal | 07/04/2010 |
Enlibrium, Inc.
 Enlibrium, Inc. Medical/Nursing ServicesHealth Services Enlibrium, Inc. provides medical services. It develops novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types. The company was founded by Michael Jung and Richard Pietras and is headquartered in La Jolla, CA. | Fondateur | - |
Anciens postes connus de Michael Jung
| Sociétés | Poste | Fin |
|---|---|---|
Seragon Pharmaceuticals, Inc.
 Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Fondateur | - |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Aragon Pharmaceuticals, Inc.
Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Health Technology |
Seragon Pharmaceuticals, Inc.
Seragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Seragon Pharmaceuticals, Inc. developes biopharmaceutical products for the treatment of estrogen receptor dependent breast cancer. The company was founded in 2013 and is headquartered in San Diego, CA. | Health Technology |
Enlibrium, Inc.
Enlibrium, Inc. Medical/Nursing ServicesHealth Services Enlibrium, Inc. provides medical services. It develops novel drugs based on the anti-cancer activity of metformin and designed to reduce cancer energy production to treat a range of cancer types. The company was founded by Michael Jung and Richard Pietras and is headquartered in La Jolla, CA. | Health Services |